Missouri Trust & Investment Company’s GSK GSK Stock Holding History

Missouri Trust & Investment Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Hold	5,500	–	–	0.08%	123
2026 Q1	$304K	Hold	5,500	–	–	0.09%	119
2025 Q4	$270K	Hold	5,500	–	–	0.08%	121
2025 Q3	$237K	Hold	5,500	–	–	0.07%	128
2025 Q2	$211K	Hold	5,500	–	–	0.07%	126
2025 Q1	$213K	Hold	5,500	–	–	0.07%	123
2024 Q4	$186K	Hold	5,500	–	–	0.07%	130
2024 Q3	$225K	Hold	5,500	–	–	0.08%	126
2024 Q2	$212K	Hold	5,500	–	–	0.08%	119
2024 Q1	$236K	Hold	5,500	–	–	0.09%	119
2023 Q4	$204K	Hold	5,500	–	–	0.08%	118
2023 Q3	$199K	Hold	5,500	–	–	0.09%	116
2023 Q2	$196K	Buy	5,500 +500	+10%	+$17.9K	0.11%	117
2023 Q1	$178K	Buy	5,000 +200	+4%	+$7K	0.11%	114
2022 Q4	$169K	Buy	4,800 +4,400	+1,100%	+$147K	0.1%	115
2022 Q3	$12K	Hold	400	–	–	0.01%	244
2022 Q2	$22K	Hold	400	–	–	0.01%	226
2022 Q1	$22K	Hold	400	–	–	0.01%	236
2021 Q4	$22K	Buy	+400	New	+$20.8K	0.01%	250

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Missouri Trust & Investment Company's GSK Position: Q2 2026 in Review

Missouri Trust & Investment Company held its GSK (GSK) position steady in Q2 2026 at 5,500 shares worth $284K. The position accounts for 0.08% of the portfolio, ranked #123.

Missouri Trust & Investment Company first reported a position in GSK in Q4 2021 and has held it in 19 quarters since. The position peaked at $304K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Missouri Trust & Investment Company held 5,500 shares of GSK worth $284K as of Q2 2026.
Missouri Trust & Investment Company left its GSK share count unchanged in Q2 2026.
GSK made up 0.08% of Missouri Trust & Investment Company's portfolio in Q2 2026, its #123 holding.
Missouri Trust & Investment Company first reported a position in GSK in Q4 2021 and has held it in 19 quarters since.
Missouri Trust & Investment Company's GSK position peaked at $304K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.